Skip to main content
Premium Trial:

Request an Annual Quote

Elias Zerhouni, John Leamon, Peter Amanatides

National Institutes of Health Director Elias Zerhouni will resign from his position at the end of October "to pursue writing projects and explore other professional opportunities." Raynard Kington, deputy director of NIH, will likely serve as acting director until a new administration names his successor. Zerhouni was appointed to the directorship of NIH in 2002 by President George W. Bush.

John Leamon has become director of molecular biology at Ion Torrent Systems in Guilford, Conn. He joined the company from RainDance Technologies, where he was a project leader.


Peter Amanatides has become vice president of quality assurance and quality control for Noven Pharmaceuticals. Prior to Noven, he held several senior positions at DSM Pharmaceuticals. Before that, he was director of quality systems at Celera Genomics. Amanatides holds an MS in biotechnology and molecular biology from Hood College and a BS in biology from Regents College.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.